Found 4 matching trials
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
PHASE1This is a Phase 1, first-in-human study designed to assess the safety, tole...
Location
ICON Early Phase Services/CRU
A Study With NLY01 in Subjects With Type 2 Diabetes
PHASE2This is a Phase 2a study designed to assess the effect of NLY01 in patients...
Location
Profil Institute fur Stoffwechselforschung GmbH
A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
PHASE2This is a phase 2 study designed to assess the safety, tolerability and eff...
Location
University of Alabama at Birmingham
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
PHASE2The goal of this clinical trial is to evaluate if the study drug will reduc...
Location
Johns Hopkins University